| Affiliation | # in City |
|---|---|
| Subordinate | 5 |
| Central | 1 |
| Central | 1 |
| Independent | 235 |
| Ruling Date Decade | # in City |
|---|---|
| 2020's | 55 |
| 2010's | 68 |
| 2000's | 64 |
| 1990's | 25 |
| 1980's | 15 |
| 1970's | 5 |
| 1960's | 5 |
| 1950's | 4 |
| N/A | 1 |
| Deductibility | # in City |
|---|---|
| Contributions are deductible | 240 |
| N/A | 1 |
| Contributions are not deductible | 1 |
| Organization | # in City |
|---|---|
| Association | 3 |
| Corporation | 230 |
| Co operative | 1 |
| Trust | 8 |
| Foundation Type | # in City |
|---|---|
| 509(a)(3) Type I | 2 |
| 30 | |
| Organizations operated solely for the benefit of and in conjunction with organizations described in 10 through 16 above. 509(a)(3) | 5 |
| Organization that normally receives no more than one third of its support from gross investment income and unrelated business income and at the same time more than one third of its support from contributions, fees, and gross receipts related to exempt purposes. 509(a)(2) | 33 |
| Organization which receives a substantial part of its support from a governmental unit or the general public 170(b)(1)(A)(vi) | 156 |
| 2 | |
| Hospital or medical research organization 170(b)(1)(A)(iii) | 8 |
| 5 | |
| School 170(b)(1)(A)(ii) | 1 |
| NTEE | # in City |
|---|---|
| Medical Research | 242 |
| Income | # in City |
|---|---|
| $50,000,000 to greater | 12 |
| $10,000,000 to $49,999,999 | 7 |
| $500,000 to $999,999 | 14 |
| $100,000 to $499,999 | 29 |
| $5,000,000 to $9,999,999 | 5 |
| $1,000,000 to $4,999,999 | 23 |
| $1 to $9,999 | 31 |
| N/A | 83 |
| $25,000 to $99,999 | 26 |
| $10,000 to $24,999 | 12 |
| Assets | # in City |
|---|---|
| $50,000,000 to greater | 13 |
| $10,000,000 to $49,999,999 | 10 |
| $500,000 to $999,999 | 14 |
| $100,000 to $499,999 | 42 |
| $5,000,000 to $9,999,999 | 5 |
| $1,000,000 to $4,999,999 | 27 |
| $1 to $9,999 | 22 |
| N/A | 79 |
| $25,000 to $99,999 | 22 |
| $10,000 to $24,999 | 8 |
Click on the save icon from a search results or organization page.